Erratum to: Allergy Asthma Clin Immunol (2016) 12:11 DOI 10.1186/s13223-016-0110-8 {#Sec1}
==================================================================================

After publication of the article \[[@CR1]\] it was brought to our attention that the incorrect length of needle was used for one of the epinephrine auto-injectors (EAI), Jext^®^. The length of the needle of the Jext^®^ 0.15 mg is not 15.7 mm as mentioned in the paper, but 13 mm. After correcting the needle length for Jext^®^, the results of the study do not change aside for those involving Jext^®^. The results of the primary outcome variable for Jext^®^ are now the same as the other high pressure EAIs (HPEAIs) and do not lead to intra-osseous injections 38% but 11% between 15 and 30 kg. This is the same risk as the Epipen^®^ and the Auvi-Q^®^.

The online version of the original article can be found under doi:10.1186/s13223-016-0110-8.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
